A group of researchers are seeking federal approval for a study that may validate what many military veterans have been saying for some time, marijuana is effective treatment for many of the illnesses vets encounter after combat.
Getting final approval from the federal government could prove difficult, [Rick Dobin and Dr. Sue Sisley] conceded. They said it was far more challenging to get authorization for a study that examines the benefits of an illegal drug than its risks.
“We really believe science should supersede politics.” Dr. Sisley said. “This illness needs to be treated in a multidisciplinary way. Drugs like Zoloft and Paxil have proven entirely inadequate. And there’s anecdotal evidence from vets that cannabis can provide systematic relief.”
Rick Dobin is founder and executive director of the Multidisciplinary Association for Psychedelic Studies in Santa Cruz California. Dr. Sisley is an assistant professor of psychiatry and internal medicine at the UNiversity of Arizona College of Medicine.
The proposed study, which will study the effects of marijuana on post traumatic stress disorder (PSTD), is awaiting approval from a scientific review panel from the Department of Health and Human Services. Once that hurdle is ovecome, the study must be further approved an institutional review board, as well as the Drug Enforcement Administration.
The use of medical marijuana is generally restricted to the treatment of diseases or conditions specifically detailed in a state’s statute. Of the 16 states and the District of Columbia in which medical marijuana is legal, only New Mexico and Delaware specifically allow marijuana to be administered for the treatment of Post traumatic Stress Disorder.
Read the entire article at The New York Times »